JLL Partners has agreed to acquire BioClinica Inc. (Nasdaq: BIOC), a Newtown, Penn.—based provider of clinical trial management solutions, for $123 million, or $7.25 per share. JLL Partners also announced an agreement to acquire Princeton, N.J.-based CoreLab Partners fromAmpersand Capital Partners, and that it would merge the two companies into a single entity.www.bioclinica.com
Hahn & Co. has agreed to acquire a control stake in bankrupt South Korean shipping company Korea Line for approximately $134 million, according to Private Equity International. www.korealines.co.kr
MBK MORE